{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:41:30Z","timestamp":1784191290876,"version":"3.55.0"},"reference-count":17,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The recent shortage of the brand name drug Fungizone has necessitated a change to generic formulations of amphotericin B deoxycholate. Clinical trials cannot be conducted in a timely manner to provide data on the safety and efficacy of these formulations. We therefore compared generic amphotericin B and Fungizone for activity and safety in the treatment of experimental invasive pulmonary aspergillosis (IPA) in persistently neutropenic rabbits. Fungizone and generic amphotericin B are similar in efficacy, pharmacokinetics, and safety in the treatment of experimental IPA.<\/jats:p>","DOI":"10.1128\/aac.49.4.1642-1645.2005","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T19:23:13Z","timestamp":1111778593000},"page":"1642-1645","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and Safety of Generic Amphotericin B in Experimental Pulmonary Aspergillosis"],"prefix":"10.1128","volume":"49","author":[{"given":"Vidmantas","family":"Petraitis","sequence":"first","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"},{"name":"SAIC-Frederick, Inc., Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Petraitiene","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"},{"name":"SAIC-Frederick, Inc., Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxin","family":"Lin","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Calis","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Warren-Grant Magnuson Clinical Center, Bethesda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Kelaher","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi A.","family":"Muray","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mya-San","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mickiene","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bacher","sequence":"additional","affiliation":[{"name":"Surgery Service, Veterinary Resources Program, Office of Research Services, National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"520","volume":"8","year":"1974","unstructured":"Alexander, M. R. 1974. Review of vancomycin after 15 years of use. Drug Intell. Clin. Pharm.8:520.","journal-title":"Drug Intell. Clin. Pharm."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.Supplement_1.S43"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1592\/phco.23.5.572.32209","volume":"23","year":"2003","unstructured":"Cleary, J. D., P. D. Rogers, and S. W. Chapman. 2003. Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations. Pharmacotherapy23:572-578.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2001.tb00006.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000238688","volume":"35","year":"1989","unstructured":"Eng, R. H., L. Wynn, S. M. Smith, and F. Tecson-Tumang. 1989. Effect of intravenous vancomycin on renal function. Chemotherapy35:320-325.","journal-title":"Chemotherapy"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.1.139-143.1997"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.2.356"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Gibaldi M. and D. Perrier. 1982. Pharmacokinetics 2nd ed. p. 55-459. Marcel Dekker Inc. New York N.Y.","DOI":"10.1201\/b14095"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(96)92700-0"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/315643"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0891-5520(20)30294-4","volume":"3","year":"1989","unstructured":"Ingerman, M. J., and J. Santoro. 1989. Vancomycin. A new old agent. Infect. Dis. Clin. N. Am.3:641-651.","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.2.310"},{"key":"e_1_3_1_14_2","unstructured":"National Committee for Clinical Laboratory Standards. 2000. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_15_2","unstructured":"National Research Council Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources Commission on Life Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press Washington D.C."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920601)69:11<2653::AID-CNCR2820691106>3.0.CO;2-8"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/516480"},{"key":"e_1_3_1_18_2","first-page":"467","volume":"38","year":"1988","unstructured":"Walsh, T. J., J. Bacher, and P. A. Pizzo. 1988. Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits. Lab. Anim. Med.38:467-470.","journal-title":"Lab. Anim. Med."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.4.1642-1645.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.4.1642-1645.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:46:26Z","timestamp":1645469186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.4.1642-1645.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1128\/AAC.49.4.1642-1645.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.4.1642-1645.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"2004-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}